I agree that this site is using cookies. You can find further informations here.
X
Giangrande, P. L. F.
215  results:
Search for persons X
?
1

European principles of inhibitor management in patients wit..:

Hermans, C. ; Giangrande, P. L. F. ; O'Mahony, B....
Orphanet Journal of Rare Diseases.  15 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
2

European principles of inhibitor management in patients wit..:

on behalf of the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD) ; Giangrande, P. L. F. ; Hermans, C....
Orphanet Journal of Rare Diseases.  13 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
3

Kreuth IV: European consensus proposals for treatment of ha..:

Giangrande, P. L. F. ; Peyvandi, F. ; O'Mahony, B....
Haemophilia.  23 (2017)  3 - p. 370-375 , 2017
Link: https://doi.org/10.1111/..
 
?
4

Management of haemophilia:

Giangrande, P.L.F.
Paediatrics and Child Health.  25 (2015)  8 - p. 350-353 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Haemophilia care in Europe – a survey of 35 countries:

O'Mahony, B. ; Noone, D. ; Giangrande, P. L. F..
Haemophilia.  19 (2013)  4 - p. , 2013
Link: https://doi.org/10.1111/..
 
?
6

Porcine factor VIII:

GIANGRANDE, P. L. F.
Haemophilia.  18 (2012)  3 - p. 305-309 , 2012
Link: https://doi.org/10.1111/..
 
?
7

Haemophilia Care in Europe: the ESCHQoL study:

Schramm, W. ; Gringeri, A. ; Ljung, R....
Haemophilia.  18 (2012)  5 - p. 729-737 , 2012
Link: https://doi.org/10.1111/..
 
?
8

Management of haemophilia:

Giangrande, P.L.F.
Paediatrics and Child Health.  21 (2011)  8 - p. 344-347 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Management of difficult‐to‐treat inhibitor patients:

GIANGRANDE, P. L. F. ; ESCOBAR, M. A.
Haemophilia.  16 (2010)  s3 - p. 52-57 , 2010
Link: https://doi.org/10.1111/..
 
?
10

Haemophilia care in Europe: a survey of 19 countries:

O'MAHONY, B. ; NOONE, D. ; GIANGRANDE, P. L. F..
Haemophilia.  17 (2010)  1 - p. 35-40 , 2010
Link: https://doi.org/10.1111/..
 
?
11

Consensus protocol for the use of recombinant activated fac..:

GIANGRANDE, P. L. F. ; WILDE, J. T. ; MADAN, B....
Haemophilia.  15 (2009)  2 - p. 501-508 , 2009
Link: https://doi.org/10.1111/..
 
?
12

Achievement of immune tolerance in a patient with haemophil..:

CURRY, N. S. ; MISBAH, S. A. ; GIANGRANDE, P. L. F..
Haemophilia.  13 (2007)  3 - p. 328-330 , 2007
Link: https://doi.org/10.1111/..
 
?
13

Gene therapy for hemophilia? No:

Giangrande, P. L. F.
Journal of Thrombosis and Haemostasis.  2 (2004)  8 - p. 1236-1237 , 2004
Link: https://doi.org/10.1111/..
 
?
14

Pharmacokinetics of activated recombinant coagulation facto..:

Villar, A. ; Aronis, S. ; Morfini, M....
Haemophilia.  10 (2004)  4 - p. 352-359 , 2004
Link: https://doi.org/10.1111/..
 
?
15

The incidence of factor VIII and factor IX inhibitors in th..:

Darby, S. C. ; Keeling, D. M. ; Spooner, R. J. D....
Journal of Thrombosis and Haemostasis.  2 (2004)  7 - p. 1047-1054 , 2004
Link: https://doi.org/10.1046/..
 
1-15